Jan 23, 2026 04:01PM
Jan 23, 2026 04:01PM
Jan 20, 2026 04:01PM
Jan 20, 2026 04:01PM
Aug 12, 2025 04:45PM
May 21, 2024 04:05PM
May 17, 2024 05:58AM Erasca (ERAS) Prices 86.5M Share Offering at $1.85/sh
May 16, 2024 08:03PM
May 16, 2024 08:00PM
May 9, 2024 04:22PM
Apr 1, 2024 01:15PM
Jun 5, 2023 04:02PM
Apr 18, 2023 09:06AM
Dec 13, 2022 08:01AM Erasca, Inc (ERAS) Announces FDA Clearance of IND Application for CNS-Penetrant KRAS G12C Inhibitor ERAS-3490 in KRAS G12C-Mutated Advanced or Metastatic Solid Tumors
Dec 9, 2022 07:34AM
Dec 9, 2022 07:32AM
Dec 9, 2022 07:32AM
Nov 30, 2022 08:02AM
Oct 20, 2022 08:00AM
Aug 11, 2022 05:22PM
Jul 18, 2022 08:06AM Erasca (ERAS) Enters Clinical Trial Collaboration and Supply Agreement with Eli Lilly (LLY) to Evaluate ERAS-601
Jun 2, 2022 08:01AM
Apr 12, 2022 04:01PM
Mar 10, 2022 08:08AM
Sep 8, 2021 08:02AM

68,144 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All